-
Track & Monitor
NewInnovation in medical: minimally invasive surgical instruments
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the medical industry’s minimally invasive surgical instruments segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.
-
Sector Analysis
NewIntra-Aortic Balloon Pump Consoles Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Intra-Aortic Balloon Pump Consoles Market Report Overview The intra-aortic balloon pump consoles market size was valued at $217 million in 2023 and will grow at a CAGR of more than 1% during 2023-2033. The increasing prevalence of cardiovascular diseases will drive market growth during the forecast period. The intra-aortic balloon pump (IABP) is a mechanical device that is used to decrease myocardial oxygen demand while at the same time increasing cardiac output. It also increases coronary blood flow and therefore...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mosnodenvir in Dengue Fever
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mosnodenvir in Dengue Fever report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mosnodenvir in Dengue Fever Drug Details: Mosnodenvir (JNJ-1802) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JNJ-87890387 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JNJ-87890387 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JNJ-87890387 in Solid Tumor Drug Details: JNJ-87890387 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JNJ-67670187 in Ulcerative Colitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JNJ-67670187 in Ulcerative Colitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JNJ-67670187 in Ulcerative Colitis Drug Details: JNJ-67670187 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JNJ-67670187 in Inflammatory Bowel Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JNJ-67670187 in Inflammatory Bowel Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JNJ-67670187 in Inflammatory Bowel Disease Drug Details: JNJ-67670187 is under...
-
Thematic Analysis
NewPharma M&A Deals Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Pharma Sector
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JNJ-2113 in Plaque Psoriasis (Psoriasis Vulgaris)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JNJ-2113 in Plaque Psoriasis (Psoriasis Vulgaris) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JNJ-2113 in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details: JNJ-2113...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JNJ-2113 in Ulcerative Colitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JNJ-2113 in Ulcerative Colitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JNJ-2113 in Ulcerative Colitis Drug Details: JNJ-2113 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Seltorexant in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Seltorexant in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Seltorexant in Alzheimer's Disease Drug Details: Seltorexant (JNJ-7922, JNJ-42847922, MIN-202) is...